Temporal arteritis historical perspective

Temporal Arteritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Temporal Arteritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Temporal arteritis historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Temporal arteritis historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Temporal arteritis historical perspective
CDC on Temporal arteritis historical perspective
Temporal arteritis historical perspective in the news
Blogs on Temporal arteritis historical perspective
Directions to Hospitals Treating Temporal arteritis
Risk calculators and risk factors for Temporal arteritis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The disease was first described in 1890 by Hutchinson. The histopathology of the disorder was first described in 1932 by Horton. Visual loss was first reported by Jennings in 1938. Birkhead first described the use of steroids to prevent progression to blindness.